Health Stock Alpha and Beta Analysis

HSAQ -  USA Stock  

USD 9.81  0.01  0.10%

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Health Sciences Acquisitions. It also helps investors analyze the systematic and unsystematic risks associated with investing in Health Sciences over a specified time horizon. Remember, high Health Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please check Health Sciences Backtesting, Health Sciences Valuation, Health Sciences Correlation, Health Sciences Hype Analysis, Health Sciences Volatility, Health Sciences History and analyze Health Sciences Performance.

Health Beta 

Please note that although Health Sciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Health Sciences did 0.07  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Health Sciences Acquisitions stock's relative risk over its benchmark. Health Sciences Acqu has a beta of 0.34  . Let's try to break down what Health's beta means in this case. As returns on the market increase, Health Sciences returns are expected to increase less than the market. However, during the bear market, the loss on holding Health Sciences will be expected to be smaller as well.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Health Sciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Health Sciences market risk premium is the additional return an investor will receive from holding Health Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Health Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Health Sciences' performance over market.
α-0.07   β0.34
90 days against DJI

Health Sciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Health Sciences' Buy-and-hold return. Our buy-and-hold chart shows how Health Sciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Health Sciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Health Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Health Sciences shares will generate the highest return on investment. By understating and applying Health Sciences stock market price indicators, traders can identify Health Sciences position entry and exit signals to maximize returns.

Health Sciences Return and Market Media

The median price of Health Sciences for the period between Sun, Oct 25, 2020 and Wed, Oct 20, 2021 is 10.5 with a coefficient of variation of 10.01. The daily time series for the period is distributed with a sample standard deviation of 1.09, arithmetic mean of 10.89, and mean deviation of 0.88. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
Wisconsin Inno - Acquisitions and tech for pandemic solution...12/08/2020
EPS Reported12/31/2020
Liberty Health Sciences Shareholders Overwhelmingly Approve ...02/23/2021
EPS Reported03/31/2021
Health Sciences Acquisitions Corp 2 falls -0.2950 percent fo...06/04/2021
EPS Reported06/30/2021
Health s 2 falls 0.30 percent on Moderate Volume July 30 - E...07/30/2021
Health Sciences Acquisitions Corp 2 falls 0.91 percent for A...08/03/2021
ASGN Incorporated Announces Acquisition of Enterprise Resour...08/09/2021
Healths 2 falls 0.10 percent on Moderate Volume August 16 - ...08/16/2021
Healths 2 falls 0.66 percent in Light Trading on August 20 -...08/20/2021
Healths 2 falls 0.61 percent for August 27 - Equities.com08/27/2021
Biotech Is Due for a Comeback. 5 Stocks That Could Lead a Re...09/03/2021
McDermott Lands 6 Transactions Partners From Several Big Law...09/23/2021
Indian Drugmaker Cipla Eyes Acquisitions After Covid Windfal...09/30/2021
Nestle S A reports nine-month sales for 2021 - marketscreene...10/19/2021

About Health Sciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Health Sciences Acqu has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Health Sciences Investors Sentiment

The influence of Health Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Health. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - HSAQ

Health Sciences Acqu Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Health Sciences Acquisitions. What is your judgment towards investing in Health Sciences Acquisitions? Are you bullish or bearish?
50% Bullish
50% Bearish

Build Portfolio with Health Sciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Health Sciences Backtesting, Health Sciences Valuation, Health Sciences Correlation, Health Sciences Hype Analysis, Health Sciences Volatility, Health Sciences History and analyze Health Sciences Performance. Note that the Health Sciences Acqu information on this page should be used as a complementary analysis to other Health Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Health Stock analysis

When running Health Sciences Acqu price analysis, check to measure Health Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Sciences is operating at the current time. Most of Health Sciences' value examination focuses on studying past and present price action to predict the probability of Health Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Health Sciences' price. Additionally, you may evaluate how the addition of Health Sciences to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Health Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Health Sciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Health Sciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...